Literature DB >> 8416602

Mechanisms of drug actions against neuronal damage caused by ischemia--an overview.

B Peruche1, J Krieglstein.   

Abstract

1. Oxygen and energy deficits induces a cascade of pathological processes which lead to neuronal dysfunction and cell death. 2. The pathogenesis of ischemia-induced neuronal damage includes a disturbed calcium homeostasis, an excessive release of EAA and an enhanced formation of free oxygen radicals. 3. Calcium antagonists inhibit Ca2+ influx into the neuronal cell via VSCC. 4. Glutamate antagonists reduce intracellular Ca2+ concentration by inactivation of NMDA receptor-associated calcium channels (NMDA antagonists) or AMPA/quisqualate receptor-linked sodium channels (non-NMDA antagonists). 5. Furthermore, oxygen radical scavengers can avoid neuronal damage. 6. Agonists of the adenosinergic and serotonergic transmitter systems contribute to neuroprotection by hyperpolarization of the neuronal membrane due to an increase of K+ permeability.

Entities:  

Mesh:

Year:  1993        PMID: 8416602     DOI: 10.1016/0278-5846(93)90032-n

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

1.  Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys.

Authors:  S A Gutnikov; D Gaffan
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

Review 2.  Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.

Authors:  Victoria E O'Collins; Malcolm R Macleod; Susan F Cox; Leena Van Raay; Elena Aleksoska; Geoffrey A Donnan; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-27       Impact factor: 6.200

3.  Altered responsiveness of the guinea-pig isolated ileum to smooth muscle stimulants and to electrical stimulation after in situ ischemia.

Authors:  Rodolfo Rodriguez; Rosa Ventura-Martinez; Jacinto Santiago-Mejia; Maria R Avila-Costa; Teresa I Fortoul
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 4.  Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models.

Authors:  Luigi Titomanlio; David Fernández-López; Lucilla Manganozzi; Raffaella Moretti; Zinaida S Vexler; Pierre Gressens
Journal:  Pediatr Neurol       Date:  2015-01-31       Impact factor: 3.372

5.  Carnosine: an endogenous neuroprotector in the ischemic brain.

Authors:  S L Stvolinsky; M L Kukley; D Dobrota; M Matejovicova; I Tkac; A A Boldyrev
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

6.  Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates.

Authors:  D V Rajakumar; M N Rao
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

7.  Protein synthesis in the hippocampal slice: transient inhibition by glutamate and lasting inhibition by ischemia.

Authors:  B Djuricic; G Röhn; W Paschen; K A Hossmann
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

8.  Calcium activity and post-ischemic suppression of protein synthesis.

Authors:  B Djuricic; G Röhn; W Paschen; K A Hossmann
Journal:  Experientia       Date:  1995-03-15

9.  Neutroprotective efficacy of sodium tanshinone B on hippocampus neuron in a rat model of focal cerebral ischemia.

Authors:  Qing Cai; Hong-Wu Wang; Sheng-Yu Hua; Jun-Zhen Tan; Tao Zhou; Chun-Shen Li
Journal:  Chin J Integr Med       Date:  2012-10-20       Impact factor: 1.978

10.  Magnesium treatment for neuroprotection in ischemic diseases of the brain.

Authors:  Thomas Westermaier; Christian Stetter; Ekkehard Kunze; Nadine Willner; Furat Raslan; Giles H Vince; Ralf-Ingo Ernestus
Journal:  Exp Transl Stroke Med       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.